|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7200 NOK | -4.00% |
|
-10.00% | -47.83% |
| 30/06 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| 26/06 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 4.55Cr 46.33L 40.5L 37.22L 34.69L 65.8L 44Cr 66.8L 4.47Cr 1.74Cr 22Cr 1.74Cr 1.7Cr 75Cr | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.16Cr 22.01L 19.24L 17.68L 16.48L 31.26L 21Cr 31.73L 2.12Cr 82.52L 10Cr 82.61L 80.83L 35Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,07,44,37,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.00% | ||
| 1 week | -10.00% | ||
| Current month | -11.66% | ||
| 1 month | -4.64% | ||
| 3 months | -55.00% | ||
| 6 months | -49.65% | ||
| Current year | -47.83% |
| 1 week | 0.67 |  | 0.86 |
| 1 month | 0.58 | | 0.93 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 3 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 24.8 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 06/06/2022 |
Svein Kvåle
COO | Chief Operating Officer | - | 01/01/2012 |
John Edminson
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 22/06/2018 | |
Anders Wold
CHM | Chairman | - | 08/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/23/04 | Buy | Chairman | 2,500 | 0.0083% | ||
| 04/23/04 | Buy | Chief Financial Officer | 2,500 | 0.0083% | ||
| 04/23/04 | Buy | Chief Executive Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.00% | -10.00% | -74.47% | -94.00% | 46.33L | |
| +2.21% | +8.45% | +4.87% | +10.75% | 4.99TCr | |
| +0.92% | +3.93% | +399.71% | +604.02% | 4.02TCr | |
| +1.89% | +8.32% | +26.06% | -6.27% | 3.46TCr | |
| +2.38% | +6.35% | +21.25% | +55.45% | 3.31TCr | |
| +3.96% | +10.67% | +8.30% | +37.95% | 2.75TCr | |
| +2.51% | +5.27% | - | - | 1.7TCr | |
| +2.58% | +5.79% | +73.44% | +135.37% | 1.59TCr | |
| +1.12% | +2.87% | +16.36% | +24.14% | 1.39TCr | |
| +3.30% | +0.76% | +90.23% | +93.88% | 1.35TCr | |
| Average | +1.69% | +4.24% | +62.86% | +95.70% | 2.46TCr | |
| Weighted average by Cap. | +2.22% | +6.53% | +90.86% | +136.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0 0 0.01 0.57 0.01 0.06 0.02 0.28 0.02 0.02 0.97 |
| Net income | -5.23Cr -53.23L -46.53L -42.76L -39.86L -75.6L -51Cr -76.75L -5.13Cr -2Cr -25Cr -2Cr -1.95Cr -86Cr | -8.7Cr -88.45L -77.33L -71.06L -66.24L -1.26Cr -84Cr -1.28Cr -8.53Cr -3.32Cr -41Cr -3.32Cr -3.25Cr -142.66Cr |
| Net Debt | -9.89Cr -1.01Cr -87.93L -80.8L -75.32L -1.43Cr -96Cr -1.45Cr -9.7Cr -3.77Cr -47Cr -3.78Cr -3.69Cr -162.21Cr | -2.39Cr -24.32L -21.26L -19.54L -18.21L -34.54L -23Cr -35.07L -2.35Cr -91.19L -11Cr -91.29L -89.33L -39Cr |
Employees
11
Calendar
03/09 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | NOK 0.7200 | -4.00% | 9,022 |
| 02/26/02 | NOK 0.7500 | -5.66% | 44,800 |
| 01/26/01 | NOK 0.7950 | -2.45% | 14,783 |
| 30/26/30 | NOK 0.8150 | +1.87% | 62,920 |
| 29/26/29 | NOK 0.8000 | 0.00% | 32,000 |
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
